DeepThink PTB is made and published by DeepThink Health. AppBrain is an independent app data site and isn't affiliated with DeepThink Health. The app name, icon, screenshots and description belong to DeepThink Health and are shown as published on the App Store.
AppBrain's verdict
Removed- Rating on App Store
- 5.00
- 4 ratings
- Last updated
- June 25, 2022
DeepThink PTB is no longer on the App Store. It had too few ratings to say what users thought.
Releases
Updates seen on the App Store- Version
- 2.02
- Launched
- November 2019
No changelog data
User feedback
Ratings and reviews on the App StoreComments on DeepThink PTB for iOS
We don't have enough comments to show example comments. Please check back later.
Technology
Found in the app by AppBrain- Price
- Free
- App size
- 34.0 MB
- Content rating
- High
Technologies used by DeepThink PTB
About the app and developer
About DeepThink PTB
DeepThink PTB was a medical app developed by DeepThink Health. It was removed from the App Store Oct 27, 2025.
User Ratings
DeepThink PTB was rated 5.00 out of 5 stars, based on 4 ratings.
App Information
DeepThink PTB was free. The app size was 34.00 MB. The last available version was 2.02. The last update was on June 25, 2022.
Technical Requirements
The app had a content rating of High Maturity. The app had been available on the App Store since November 2019.
Developer information for DeepThink Health
Address:
Store listing
By DeepThink Health, from the App StoreSimilar apps
Description by DeepThink Health Written by the developer, not by AppBrain. Click to read.
Advancing medicine with precision intelligence ™
DeepThink Health has developed an innovative precision intelligence platform which captures and structures large clinical and genomic datasets, and then applies our advanced analytics and machine learning to enable precision medicine. Just as in the desktop Precision Tumor Board application, in our mobile app we’ve integrated and processed a cancer patient’s molecular/genomic tumor report enabling Molecular Tumor Board and Standard Tumor Board to quickly interpret the complex data for oncologists urgently needing to prescribe the right therapies for their cancer patients. Tumor Board members can:
• Quickly see FDA approved therapies with predictive responses for the patient’s specific tumor type and genetic characteristics
• Easily select among targeted therapies based on biomarkers or suggest therapies to enhance the molecular report interpretation
• See clinical trials already screened for the patient case in context
• Collaborate with other Molecular Tumor Board members to quickly and timely provide a succinct report to the treating oncologist
• Schedule and hold virtual tumor board meeting
• No private health information is stored or relayed in the application, DeepThink Health products are HIPAA compliant.
About DeepThink Health
DeepThink Health has developed an innovative precision intelligence platform which captures and structures large clinical and genomic datasets, and then applies our advanced analytics and machine learning to enable precision medicine. Our team has extensive experience and success in leading Healthcare IT companies serving providers, payers and pharmacies. Our Precision Analytics and Precision Intelligence solutions have been successfully implemented at large Healthcare IDNs where the combined genomic, clinical and outcome data were analyzed using DeepThink Artificial Intelligence tools to advance precision medicine and enable novel discoveries.